Diagnosis and treatment of pancreatic acinar cell carcinoma
10.3877/cma.j.issn.2095-3232.2024.04.008
- Collective Name:Wu Shuai, Wu Jiaoxing, Wang Fangzhou, Yang Peize, Dong Shunbin, Wang Zheng, Wu Zheng
- Publication Type:Journal Article
- From:
Chinese Journal of Hepatic Surgery（Electronic Edition）
2024;13(4):487-
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic acinar cell carcinoma (PACC) is a malignant epithelial tumor arising from pancreatic epithelium, which is rare in clinical practice due to low incidence, and it has no specific clinical
manifestations. Previous studies have reported that PACC accounts for merely 1%-2% of exocrine pancreatic tumors and 0.44% of pancreatic malignant tumors. This disease is challenging to diagnose, has low resection rates, and easily metastasizes. However, the prognosis is better than that of pancreatic ductal adenocarcinoma.Understanding and mastering clinical diagnosis and treatment of PACC can improve diagnostic rate and
clinical prognosis.
- Full text:2025022616171028447487.pdf
